Clinical (prescription) cannabis solutions have been rescheduled in the UK in 2018 — this authorized professional Health professionals to prescribe cannabis-dependent medicines in the constrained set of instances. Accessibility through the NHS continues to be tightly restricted: cannabis-centered products and solutions tend to be only prescribed